Results 51 to 56 of about 6,137 (56)

A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada. [PDF]

open access: yesPharmacoecon Open, 2023
Chatterjee A   +7 more
europepmc   +1 more source

Venetoclax in Combination with Obinutuzumab in Previously Untreated Fit Patients with Chronic Lymphocytic Leukemia: A Canadian Cost-Utility Analysis. [PDF]

open access: yesPharmacoecon Open
van de Wetering G   +10 more
europepmc   +1 more source

Association of FTO variants rs9939609 and rs1421085 with elevated sugar and fat consumption in adult obesity. [PDF]

open access: yesSci Rep
Poosri S   +5 more
europepmc   +1 more source

Advances in silicon carbide pressure sensors for high-temperature extreme environment sensing. [PDF]

open access: yesMicrosyst Nanoeng
Wu C   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy